| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Artemisinin | Alzheimer's Disease | 3 | PM | 36902054 | 📋 | Loss of Extrasynaptic Inhibitory Glycine Receptors in the Hippocampus of an AD Mouse Model Is Restored by Treatment with Artesunate |
| Artemisinin | Alzheimer's Disease | 2 | PM | 35683033 | 📋 | Artemisinin Attenuates Amyloid-Induced Brain Inflammation and Memory Impairments by Modulating TLR4/NF-κB Signaling |
| Artemisinin | Alzheimer's Disease | 1 | PM | 35598091 | 📋 | Artesunate restores mitochondrial fusion-fission dynamics and alleviates neuronal injury in Alzheimer's disease models |
| Artemisinin | Neurodegenerative Disease | 2 | PM | 36464748 | 📋 | Repurposing artemisinins as neuroprotective agents: a focus on the PI3k/Akt signalling pathway |
| Artemisinin | Neurodegenerative Disease | 1 | PM | 31089038 | 📋 | More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration |
| Artemisinin | Parkinson's Disease | 3 | PM | 38056239 | 📋 | Artemisinin protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in a mouse model of Parkinson's disease |
| Artemisinin | Parkinson's Disease | 2 | PM | 37513399 | 📋 | Artemisinin Confers Neuroprotection against 6-OHDA-Induced Neuronal Injury In Vitro and In Vivo through Activation of the ERK1/2 Pathway |
| Artemisinin | Parkinson's Disease | 1 | PM | 36691817 | 📋 | Artemisinin exerts a protective effect in the MPTP mouse model of Parkinson's disease by inhibiting microglial activation via the TLR4/Myd88/NF-KB pathway |
